Ge Zhiqiang, Ji Qinggang, Chen Chunyan, Liao Qin, Wu Hualong, Liu Xiaofei, Huang Yanrong, Yuan Lvjiang, Liao Fei
a Key Laboratory of Applied Chemistry of Chongqing Municipality , School of Chemistry and Chemical Engineering, Southwest University , Chongqing , PR China and.
b Unit for Analytical Probe and Protein Biotechnology, Key Laboratory of Clinical Laboratory Diagnostics of the Education Ministry , College of Laboratory Medicine, Chongqing Medical University , Chongqing , PR China.
J Enzyme Inhib Med Chem. 2016;31(2):219-28. doi: 10.3109/14756366.2015.1016511. Epub 2015 Sep 25.
A series of novel 3-substituted amino-4-hydroxycoumarin derivatives have been designed and synthesized as chitin synthase (CHS) inhibitors. All the synthesized compounds have been screened for their CHS inhibition activity and antimicrobial activity in vitro. The enzymatic assay indicated that most of the compounds have good inhibitory activity against CHS, in which compound 6o with IC50 of 0.10 mmol/L had stronger activity than that of polyoxins B, which acts as control drug with IC50 of 0.18 mmol/L. As far as the antifungal activity is concerned, most of the compounds possessed moderate to excellent activity against some representative pathogenic fungi. Especially, compound 6b was found to be the most potent agent against Cryptococcus neoformans with minimal inhibitory concentration (MIC) of 4 μg/mL. Moreover, the results of antibacterial screening showed that these compounds have negligible actions to some tested bacteria. Therefore, these compounds would be promising to develop selective antifungal agents.
设计并合成了一系列新型的3-取代氨基-4-羟基香豆素衍生物作为几丁质合成酶(CHS)抑制剂。对所有合成的化合物进行了体外CHS抑制活性和抗菌活性筛选。酶活性测定表明,大多数化合物对CHS具有良好的抑制活性,其中IC50为0.10 mmol/L的化合物6o比作为对照药物的多氧霉素B(IC50为0.18 mmol/L)具有更强的活性。就抗真菌活性而言,大多数化合物对一些代表性致病真菌具有中度至优异的活性。特别是,发现化合物6b是针对新型隐球菌的最有效药物,其最低抑菌浓度(MIC)为4 μg/mL。此外,抗菌筛选结果表明这些化合物对一些受试细菌的作用可忽略不计。因此,这些化合物有望开发成为选择性抗真菌剂。